Michael Petusky

Stock Analyst at Barrington Research

(0)
# 4063
Out of 5,218 analysts
173
Total ratings
46.48%
Success rate
-3.73%
Average return
19 Stocks
Name Action Price Target Current % Upside Ratings Updated
Haemonetics
Maintains: Outperform
108 108
81.16 33.07% 22 Dec 4, 2024
US Physical Therapy
Maintains: Outperform
108 108
93.33 15.72% 21 Nov 21, 2024
ModivCare
Maintains: Outperform
25 25
17.91 39.59% 12 Nov 18, 2024
VerifyMe
Maintains: Outperform
2 2
0.62 141.94% 8 Nov 13, 2024
OPKO Health
Maintains: Outperform
3 3
1.59 41.51% 9 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 24
19.75 21.52% 17 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
82 82
76.59 7.06% 11 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
92 93
100.34 -7.32% 8 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
37 25
17.14 45.86% 15 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
114 114
102.83 10.86% 15 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 32
23.5 36.17% 11 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 Aug 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 12
n/a n/a 6 Oct 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Jul 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
n/a n/a 1 Jun 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Dec 18, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 1 Aug 3, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 1 Aug 11, 2016